Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Last week’s full-year results from GlaxoSmithKline (GSK) do not answer every concern the sceptics may have regarding current ...
Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run ...
GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
DAVENPORT & Co LLC lessened its position in shares of GSK plc (NYSE:GSK – Free Report) by 4.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results